Literature DB >> 20677216

Characterization of murine SIRT3 transcript variants and corresponding protein products.

Yongjie Yang1, Basil P Hubbard, David A Sinclair, Qiang Tong.   

Abstract

SIRT3 is one of the seven mammalian sirtuin homologs of the yeast SIR2 gene. SIRT3 possesses NAD(+)-dependent protein deacetylase activity. Recent studies indicate that the murine SIRT3 gene expresses different transcript variants, resulting in three possible SIRT3 protein isoforms with various lengths at the N-terminus: M1 (aa 1-334), M2 (aa 15-334), and M3 (aa 78-334). The transcript variants 1 and 3 can only produce M3 protein, while M1 and M2 proteins are translationally initiated from different in-frame ATG sites in transcript 2. Here we report that three transcript variants of the mouse SIRT3 gene are broadly expressed in various mouse tissues. By expressing these SIRT3 isoforms in HEK293 cells through transient transfection, we confirmed recent reports that two longer murine SIRT3 proteins (M1 and M2) are targeted to mitochondria with higher efficiency than the shorter M3 isoform. Additionally, the M1 and M2 proteins are processed into a mature form. Using Edman degradation we identify Ile38 (majority) or Val42 as the N-terminal amino acid of the mature M1 isoform, and Met78 or Val79 as the N-terminal amino acid of the M3 isoform. Interestingly, we found that even upon mutation of the M2 ATG site in the M1 cDNA, a processed mature protein could still be produced. In terms of deacetylase activity, we found that although only the mature protein derived from M1 or M2 proteins were active against acetylated peptide substrates, all three forms had equal deacetylase activity towards a full-length native protein substrate, acetyl CoA synthetase 2.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677216      PMCID: PMC3558747          DOI: 10.1002/jcb.22795

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  31 in total

1.  Crystal structures of mitochondrial processing peptidase reveal the mode for specific cleavage of import signal sequences.

Authors:  A B Taylor; B S Smith; S Kitada; K Kojima; H Miyaura; Z Otwinowski; A Ito; J Deisenhofer
Journal:  Structure       Date:  2001-07-03       Impact factor: 5.006

2.  Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms.

Authors:  Jianjun Bao; Zhongping Lu; Joshua J Joseph; Darin Carabenciov; Christopher C Dimond; Liyan Pang; Leigh Samsel; J Philip McCoy; Jaime Leclerc; Phuongmai Nguyen; David Gius; Michael N Sack
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

3.  Cloning and characterization of two mouse genes with homology to the yeast Sir2 gene.

Authors:  Y H Yang; Y H Chen; C Y Zhang; M A Nimmakayalu; D C Ward; S Weissman
Journal:  Genomics       Date:  2000-11-01       Impact factor: 5.736

4.  Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria.

Authors:  Huseyin Cimen; Min-Joon Han; Yongjie Yang; Qiang Tong; Hasan Koc; Emine C Koc
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

5.  SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.

Authors:  Matthew D Hirschey; Tadahiro Shimazu; Eric Goetzman; Enxuan Jing; Bjoern Schwer; David B Lombard; Carrie A Grueter; Charles Harris; Sudha Biddinger; Olga R Ilkayeva; Robert D Stevens; Yu Li; Asish K Saha; Neil B Ruderman; James R Bain; Christopher B Newgard; Robert V Farese; Frederick W Alt; C Ronald Kahn; Eric Verdin
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

6.  Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle.

Authors:  Orsolya M Palacios; Juan J Carmona; Shaday Michan; Ke Yun Chen; Yasuko Manabe; Jack Lee Ward; Laurie J Goodyear; Qiang Tong
Journal:  Aging (Albany NY)       Date:  2009-08-15       Impact factor: 5.682

7.  Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Gene Kim; Madhu Gupta; Senthilkumar B Rajamohan; Jyothish B Pillai; Sadhana Samant; P V Ravindra; Ayman Isbatan; Mahesh P Gupta
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

8.  NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10.

Authors:  Yongjie Yang; Huseyin Cimen; Min-Joon Han; Tong Shi; Jian-Hong Deng; Hasan Koc; Orsolya M Palacios; Laura Montier; Yidong Bai; Qiang Tong; Emine C Koc
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

Review 9.  Mitochondrial processing peptidases.

Authors:  Oleksandr Gakh; Patrizia Cavadini; Grazia Isaya
Journal:  Biochim Biophys Acta       Date:  2002-09-02

10.  The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase.

Authors:  Bjorn Schwer; Brian J North; Roy A Frye; Melanie Ott; Eric Verdin
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

View more
  22 in total

1.  trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.

Authors:  Jinrong Fu; Jing Jin; Robert H Cichewicz; Serena A Hageman; Trevor K Ellis; Lan Xiang; Qi Peng; Mali Jiang; Nicolas Arbez; Katelyn Hotaling; Christopher A Ross; Wenzhen Duan
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Megalin mediates plasma membrane to mitochondria cross-talk and regulates mitochondrial metabolism.

Authors:  Qingtian Li; Fan Lei; Yi Tang; Jenny Szu-Chin Pan; Qiang Tong; Yuxiang Sun; David Sheikh-Hamad
Journal:  Cell Mol Life Sci       Date:  2018-06-09       Impact factor: 9.261

Review 3.  Mitochondrial sirtuins in the regulation of mitochondrial activity and metabolic adaptation.

Authors:  David B Lombard; Daniel X Tishkoff; Jianjun Bao
Journal:  Handb Exp Pharmacol       Date:  2011

4.  Murine Sirt3 protein isoforms have variable half-lives.

Authors:  Yongjie Yang; Ke Yun Chen; Qiang Tong
Journal:  Gene       Date:  2011-08-05       Impact factor: 3.688

5.  Muscle-specific sirtuin 3 overexpression does not attenuate the pathological effects of high-fat/high-sucrose feeding but does enhance cardiac SERCA2a activity.

Authors:  Christopher J Oldfield; Teri L Moffatt; Kimberley A O'Hara; Bo Xiang; Vernon W Dolinsky; Todd A Duhamel
Journal:  Physiol Rep       Date:  2021-08

6.  Analysis of 41 cancer cell lines reveals excessive allelic loss and novel mutations in the SIRT1 gene.

Authors:  Jeehae Han; Basil P Hubbard; Jaehoon Lee; Cristina Montagna; Han-Woong Lee; David A Sinclair; Yousin Suh
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

7.  Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.

Authors:  Kyle G Cheung; Laura K Cole; Bo Xiang; Keyun Chen; Xiuli Ma; Yvonne Myal; Grant M Hatch; Qiang Tong; Vernon W Dolinsky
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

Review 8.  SIRT3: as simple as it seems?

Authors:  David B Lombard; Bernadette M M Zwaans
Journal:  Gerontology       Date:  2013-10-25       Impact factor: 5.140

9.  Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism.

Authors:  Basil P Hubbard; Christine Loh; Ana P Gomes; Jun Li; Quinn Lu; Taylor Lg Doyle; Jeremy S Disch; Sean M Armour; James L Ellis; George P Vlasuk; David A Sinclair
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

10.  Skeletal muscle overexpression of short isoform Sirt3 altered mitochondrial cardiolipin content and fatty acid composition.

Authors:  Béatrice Chabi; Gilles Fouret; Jérome Lecomte; Fabienne Cortade; Laurence Pessemesse; Narjès Baati; Charles Coudray; Ligen Lin; Qiang Tong; Chantal Wrutniak-Cabello; François Casas; Christine Feillet-Coudray
Journal:  J Bioenerg Biomembr       Date:  2018-03-27       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.